| Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis ML Bastos, G Tavaziva, SK Abidi, JR Campbell, LP Haraoui, JC Johnston, ... bmj 370, 2020 | 962 | 2020 |
| Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis M Yanes-Lane, N Winters, F Fregonese, M Bastos, S Perlman-Arrow, ... Plos one 15 (11), e0241536, 2020 | 361 | 2020 |
| Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis Z Lan, N Ahmad, P Baghaei, L Barkane, A Benedetti, SK Brode, ... The Lancet Respiratory Medicine 8 (4), 383-394, 2020 | 192 | 2020 |
| The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis ML Bastos, S Perlman-Arrow, D Menzies, JR Campbell Annals of Internal Medicine, 2021 | 189 | 2021 |
| Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis JP Samuels, A Sood, JR Campbell, F Ahmad Khan, JC Johnston Scientific reports 8 (1), 4980, 2018 | 88 | 2018 |
| Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis JR Campbell, N Winters, D Menzies bmj 368, 2020 | 86 | 2020 |
| Metal release from hip prostheses: cobalt and chromium toxicity and the role of the clinical laboratory JR Campbell, MP Estey Clinical Chemistry and Laboratory Medicine (CCLM) 51 (1), 213-220, 2013 | 78 | 2013 |
| A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants JR Campbell, J Krot, K Elwood, V Cook, F Marra Molecular diagnosis & therapy 19, 9-24, 2015 | 76 | 2015 |
| Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis S Abidi, J Achar, MMA Neino, D Bang, A Benedetti, S Brode, JR Campbell, ... European Respiratory Journal 55 (3), 2020 | 70 | 2020 |
| Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis GP Bisson, M Bastos, JR Campbell, D Bang, JC Brust, P Isaakidis, ... The Lancet 396 (10248), 402-411, 2020 | 59 | 2020 |
| Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis K Romanowski, RF Balshaw, A Benedetti, JR Campbell, D Menzies, ... Thorax 74 (3), 291-297, 2019 | 57 | 2019 |
| Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials JR Campbell, A Trajman, VJ Cook, JC Johnston, M Adjobimey, R Ruslami, ... The Lancet Infectious Diseases, 2019 | 54 | 2019 |
| Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis L Mota, K Al-Efraij, JR Campbell, VJ Cook, F Marra, J Johnston The International Journal of Tuberculosis and Lung Disease 20 (6), 819-826, 2016 | 52 | 2016 |
| Chest X-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: an individual patient data meta-analysis of diagnostic accuracy G Tavaziva, M Harris, SK Abidi, C Geric, M Breuninger, K Dheda, ... Clinical Infectious Diseases, 2021 | 47 | 2021 |
| Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis JR Campbell, W Chen, J Johnston, V Cook, K Elwood, J Krot, F Marra Molecular diagnosis & therapy 19, 107-117, 2015 | 45 | 2015 |
| Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South … N Ndjeka, JR Campbell, G Meintjes, G Maartens, HS Schaaf, J Hughes, ... The Lancet Infectious Diseases 22 (7), 1042-1051, 2022 | 42 | 2022 |
| Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs JR Campbell, A Uppal, O Oxlade, F Fregonese, ML Bastos, Z Lan, S Law, ... CMAJ 192 (40), E1146-E1155, 2020 | 39 | 2020 |
| Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries JR Campbell, D Dowdy, K Schwartzman PLoS medicine 16 (6), e1002824, 2019 | 37 | 2019 |
| A systematic review of studies evaluating the cost utility of screening high-risk populations for latent tuberculosis infection JR Campbell, T Sasitharan, F Marra Applied health economics and health policy 13, 325-340, 2015 | 34 | 2015 |
| Demographic predictors of active tuberculosis in people migrating to British Columbia, Canada: a retrospective cohort study LA Ronald, JR Campbell, RF Balshaw, K Romanowski, DZ Roth, F Marra, ... CMAJ 190 (8), E209-E216, 2018 | 33 | 2018 |
James JohnstonClinical Professor, BCCDC and UBC Respiratory MedicineVerified email at bccdc.ca
